DEERFIELD MANAGEMENT COMPANY, L.P.
Position in KYTX — Kyverna Therapeutics, Inc.
CIK 1009258
NEW YORK, NY
Position in KYTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$17,260,000
-$1,540,000 QoQ
Shares Held
2,000,000
0.0% QoQ
Ownership
3.29%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KYTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DEERFIELD MANAGEMENT COMPANY, L.P. holds $5,090,522,306 across 44 Biotechnology names. KYTX ranks #37 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NUVL |
Nuvalent, Inc.
|
17,248,450 | $1,767,103,702 | |
| 2 | COGT |
Cogent Biosciences, Inc.
|
9,043,903 | $348,099,826 | |
| 3 | PRAX |
Praxis Precision Medicines, Inc.
|
963,351 | $310,382,058 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
2,297,000 | $223,383,250 | |
| 5 | CELC |
Celcuity Inc.
|
1,714,000 | $195,635,960 | |
| 6 | LRMR |
Larimar Therapeutics, Inc.
|
35,606,974 | $160,231,383 | |
| 7 | VERA |
Vera Therapeutics, Inc.
|
3,722,100 | $149,740,083 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
1,979,669 | $148,653,345 |
All Filings in KYTX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,260,000 | 2,000,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $18,800,000 | 2,000,000 | Shares | Defined | 2026-02-17 | |
| 2024-09-30 | $4,493,381 | 918,892 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $14,872,500 | 1,983,000 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $36,324,451 | 1,462,337 | Shares | Defined | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||